Xiaoxiao Kong
- Molecular Biology
- Infectious Diseases
- Environmental Chemistry
- Plant Science
- Health, Toxicology and Mutagenesis
- Co-authors
- Richard L. HellmichJoel R. CoatsNena AleksicEric BoerwinkleGregory S. LadicsAdrian TanJames S. PankowWeihong Tang
- Topics
- SARS-CoV-2 and COVID-19 Research (7 papers)COVID-19 Clinical Research Studies (4 papers)Enterobacteriaceae and Cronobacter Research (3 papers)
- Journals
- BloodBioinformaticsTechnometrics
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoxiao Kong
24 papers receiving 346 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 98
- Infectious Diseases 65
- Environmental Chemistry 41
- Plant Science 41
- Health, Toxicology and Mutagenesis 40
Countries citing papers authored by Xiaoxiao Kong
This map shows the geographic impact of Xiaoxiao Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiao Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiao Kong more than expected).
Fields of papers citing papers by Xiaoxiao Kong
This network shows the impact of papers produced by Xiaoxiao Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiao Kong. The network helps show where Xiaoxiao Kong may publish in the future.
Co-authorship network of co-authors of Xiaoxiao Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiao Kong. A scholar is included among the top collaborators of Xiaoxiao Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiao Kong. Xiaoxiao Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 24 | |
| 8 | 15 | |
| 9 | 12 | |
| 10 | 6 | |
| 11 | 1 | |
| 12 | 43 | |
| 13 | 29 | |
| 14 | 16 | |
| 15 | 40 | |
| 16 | 13 | |
| 17 | 60 | |
| 18 | 11 | |
| 19 | 9 | |
| 20 | 14 |
About Xiaoxiao Kong
Xiaoxiao Kong is a scholar working on Endocrinology, Infectious Diseases and Molecular Medicine, having authored 28 papers that have together received 358 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). The work is most often cited by research in Internal Medicine (21 citations), Environmental Chemistry (41 citations) and Endocrinology (19 citations). Xiaoxiao Kong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Richard L. Hellmich, Joel R. Coats, Nena Aleksic, Eric Boerwinkle, Gregory S. Ladics, Adrian Tan, James S. Pankow, Weihong Tang, Saonli Basu and Aaron R. Folsom. Their work appears in journals such as Blood, Bioinformatics and Technometrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.